TELA Bio, Inc.·4

Feb 27, 7:19 PM ET

Murphy Peter C. 4

4 · TELA Bio, Inc. · Filed Feb 27, 2023

Insider Transaction Report

Form 4
Period: 2023-02-23
Murphy Peter C.
Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-02-23$10.50/sh906$9,51339,090 total
  • Tax Payment

    Common Stock

    2023-02-24$11.03/sh940$10,36838,150 total
  • Award

    Common Stock

    2023-02-23+16,80039,996 total
  • Award

    Stock Option (Right to Buy)

    2023-02-23+26,40026,400 total
    Exercise: $10.50Exp: 2033-02-23Common Stock (26,400 underlying)
Footnotes (3)
  • [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates.
  • [F2]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
  • [F3]The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES